Rituximab-Induced Crohn's Disease-like Colitis Following Treatment for Post-transplant Lymphoproliferative Disorder in Chronic Active Epstein-Barr Virus Infection: A Case Report. (PubMed, Intern Med) - Oct 1, 2026 - "Treatment with an infliximab biosimilar induced clinical and endoscopic remission. This case highlights rituximab-associated Crohn's colitis as a rare but important complication."
Journal • Bone Marrow Transplantation • Crohn's disease • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Gastroenterology • Gastrointestinal Disorder • Graft versus Host Disease • Immunology • Infectious Disease • Inflammatory Bowel Disease • Transplantation • Vasculitis
|
|
Hiroki Kitamoto; Hiroshi Seno; Junya Kanda; Kanako Higaki; Makoto Okabe; Mio Namikawa; Noriyoshi Yoshinaga; Rika Shimizu; Seiya Bamba; Takashi Fuyuno; Yusuke Onoyama
|